Apotex Suffers Defeat In Acular Dispute
In a major setback for Apotex Inc., a federal judge has found that the Canadian drug maker's application for a generic version of anti-inflammatory eye treatment Acular infringed a patent held...To view the full article, register now.
Already a subscriber? Click here to view full article